AIDS Therapies (Protease Inhibitors)

Drugs Proving To Slow AIDS Deaths

Published in AIDS Weekly, March 31st, 1997

Until recently, the staff of the Tidewater AIDS Crisis Taskforce in Norfolk, Virginia, mourned at least a dozen deaths a month from the disease. Now, they rarely hear of more than two a month.

Nationally, the AIDS epidemic has taken a dramatic turn, changing possibly from a terminal disease to a chronic illness. A "cocktail" of expensive, experimental drugs is forcing HIV to retreat, with much of the credit going to protease inhibitors introduced in the past two years.

U.S. deaths from AIDS fell 13 percent to 22,000 in the first half of 1996, from 24,900 a year earlier, federal health officials reported February 27, 1997. In Virginia, there was a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-03-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry